Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology Indian Medical PG Practice Questions and MCQs

Question 41: Which of the following drugs has no cycloplegic action?

A. Atropine
B. Cyclopentolate
C. Tropicamide
D. Phenylephrine (Correct Answer)

Explanation: **Explanation:** To understand the action of these drugs, one must distinguish between **Mydriasis** (dilation of the pupil) and **Cycloplegia** (paralysis of the ciliary muscle/loss of accommodation). **1. Why Phenylephrine is the Correct Answer:** Phenylephrine is a **selective alpha-1 adrenergic agonist**. It works by stimulating the dilator pupillae muscle of the iris, causing **active mydriasis**. Crucially, it has no effect on the cholinergic receptors of the ciliary muscle. Therefore, it causes pupillary dilation **without** affecting accommodation (no cycloplegia). **2. Why the Other Options are Incorrect:** * **Atropine, Cyclopentolate, and Tropicamide** are all **parasympatholytic (anticholinergic)** drugs. They block the muscarinic receptors ($M_3$) on both the sphincter pupillae and the ciliary muscle. * Blocking the sphincter pupillae causes **passive mydriasis**. * Blocking the ciliary muscle causes **cycloplegia** (paralysis of accommodation). Thus, these drugs are classified as "Mydriatic-cycloplegics." **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** * **Atropine:** Refraction in children < 5 years (due to strong accommodation) and treatment of Uveitis. * **Cyclopentolate:** Refraction in children 5–15 years. * **Tropicamide:** Routine fundus examination in adults (fastest onset, shortest duration). * **Phenylephrine** is often used in combination with Tropicamide to achieve maximal mydriasis for cataract surgery, but it is **contraindicated** in patients with narrow-angle glaucoma and should be used cautiously in hypertensive patients. * **Duration of Action (Longest to Shortest):** Atropine (7–10 days) > Homatropine (2–3 days) > Cyclopentolate (24 hours) > Tropicamide (4–6 hours).

Question 42: Timolol is preferred in glaucoma over pilocarpine because:

A. It is more effective than pilocarpine
B. It enhances uveoscleral outflow
C. It produces fewer ocular side effects (Correct Answer)
D. It has no contraindications

Explanation: **Explanation:** The preference for **Timolol** (a non-selective beta-blocker) over **Pilocarpine** (a miotic/cholinergic agonist) in the management of glaucoma is primarily due to its superior **tolerability and safety profile.** **1. Why Option C is Correct:** Pilocarpine causes significant ocular side effects due to its action on the ciliary muscle and iris sphincter. These include **accommodative spasm** (leading to induced myopia), **miosis** (causing night blindness and constricted visual fields), and **brow ache**. In contrast, Timolol lowers intraocular pressure (IOP) by reducing aqueous humor production from the ciliary body without affecting pupil size or accommodation, resulting in significantly fewer ocular side effects. **2. Why Other Options are Incorrect:** * **Option A:** While Timolol is highly effective, the primary reason for its preference is not necessarily a greater magnitude of IOP reduction, but rather the lack of vision-disrupting side effects seen with miotics. * **Option B:** Timolol works by **decreasing aqueous production**. It does not enhance uveoscleral outflow (that is the mechanism of Prostaglandin analogues like Latanoprost). * **Option D:** Timolol has significant **systemic contraindications**. Due to systemic absorption, it can cause bronchospasm and bradycardia; thus, it is contraindicated in patients with **Asthma, COPD, or Heart Block.** **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Timolol blocks $\beta_2$ receptors in the ciliary epithelium. * **Drug of Choice:** While Timolol was historically the first line, **Prostaglandin Analogues (PGAs)** are now the current first-line treatment for Open Angle Glaucoma due to once-daily dosing and superior efficacy. * **Pilocarpine Risk:** It is a known risk factor for **Retinal Detachment** due to the tractional forces exerted on the peripheral retina during ciliary muscle contraction.

Question 43: Fundus fluorescein angiography is least useful in which of the following conditions?

A. Diabetic retinopathy
B. Central serous retinopathy
C. Cystoid macular edema
D. None of the above (Correct Answer)

Explanation: **Explanation:** Fundus Fluorescein Angiography (FFA) is a diagnostic procedure that utilizes the fluorescent properties of sodium fluorescein dye to visualize the retinal and choroidal circulation. It is the "gold standard" for assessing the physiological integrity of the blood-retinal barrier. **Why "None of the above" is correct:** FFA is highly useful and often essential in the management of all three conditions listed. Since it plays a critical role in diagnosing and guiding treatment for each, none of them can be classified as "least useful." **Analysis of Options:** * **Diabetic Retinopathy (DR):** FFA is vital for identifying areas of **capillary non-perfusion (CNP)**, detecting subtle microaneurysms, and distinguishing between Intraretinal Microvascular Abnormalities (IRMA) and Neovascularization (NVD/NVE). It guides laser photocoagulation by pinpointing leakages. * **Central Serous Retinopathy (CSR):** FFA is diagnostic, typically showing classic patterns such as the **"Ink-blot"** appearance (most common) or the **"Smoke-stack"** appearance (pathognomonic) due to dye leakage through the Retinal Pigment Epithelium (RPE). * **Cystoid Macular Edema (CME):** FFA reveals a characteristic **"Petaloid pattern"** of hyperfluorescence in the late phases due to dye accumulation in the Henle’s layer (outer plexiform layer) of the retina. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dye Used:** 5-10 ml of 10% or 25% Sodium Fluorescein. 2. **Filter Mechanism:** Uses a **Blue excitation filter** (465-490 nm) and a **Yellow-green barrier filter** (520-530 nm). 3. **Side Effects:** Nausea (most common), yellowish skin/urine discoloration (transient), and rarely, life-threatening anaphylaxis. 4. **Contraindication:** History of severe allergic reaction to fluorescein dye. 5. **Comparison:** While Optical Coherence Tomography (OCT) is better for quantifying thickness, FFA remains superior for assessing **vascular perfusion and leakage.**

Question 44: Which one of the following statements is true about dipivefrine?

A. It is a prodrug.
B. It causes vasoconstriction.
C. It penetrates the cornea and is converted to epinephrine. (Correct Answer)
D. It decreases intraocular pressure.

Explanation: **Explanation:** Dipivefrine is a classic example of a **prodrug** used in the management of glaucoma. It is formed by the esterification of epinephrine with pivalic acid. **1. Why Option C is correct:** The primary limitation of epinephrine in ocular therapy is its poor corneal penetration due to its polar (hydrophilic) nature. Dipivefrine is **lipophilic**, making it **17 times more permeable** to the cornea than epinephrine. Once it penetrates the corneal epithelium, it is hydrolyzed by esterases into its active form, **epinephrine**, which then acts on $\alpha$ and $\beta$ receptors to reduce intraocular pressure (IOP). **2. Analysis of other options:** * **Option A:** While dipivefrine *is* a prodrug, in the context of NEET-PG questions where multiple statements might be technically true, Option C is the **most specific and definitive description** of its pharmacological mechanism. (Note: In many versions of this question, Option A is considered a "distractor" or the question asks for the *most* accurate description of its behavior). * **Option B:** While the converted epinephrine causes vasoconstriction, dipivefrine itself is inactive until converted. * **Option D:** Dipivefrine does decrease IOP, but again, Option C describes the unique pharmacological property that defines this drug in textbooks. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Reduces IOP by increasing uveoscleral outflow (via $\beta_2$ receptors) and decreasing aqueous humor production. * **Advantage:** Because it is more potent at lower concentrations, it has **fewer systemic side effects** (like tachycardia or hypertension) compared to epinephrine. * **Adverse Effect:** Can cause **Adrenochrome deposits** in the conjunctiva and may trigger **cystoid macular edema (CME)** in aphakic patients. * **Contraindication:** Avoid in narrow-angle glaucoma as it can cause pupillary dilation (mydriasis).

Question 45: Vortex keratopathy is seen with all the following drugs except:

A. Phenothiazines
B. Tamoxifen
C. Indomethacin
D. Thioxanthines (Correct Answer)

Explanation: **Explanation:** **Vortex Keratopathy (Cornea Verticillata)** is characterized by fine, golden-brown or greyish-white whorl-like opacities in the corneal epithelium. It occurs due to the deposition of drugs or their metabolites within the lysosomes of corneal epithelial cells (a form of drug-induced lipidosis). **Why Thioxanthines is the correct answer:** Thioxanthines (antipsychotics like Thiothixene) are primarily associated with **pigmentary deposits on the corneal endothelium and anterior lens capsule**, rather than the epithelial whorl patterns seen in vortex keratopathy. Therefore, it is the "except" in this list. **Analysis of Incorrect Options:** * **Phenothiazines:** Specifically **Chlorpromazine**, can cause vortex keratopathy, although it is more classically known for causing "star-shaped" anterior subcapsular cataracts and endothelial deposits. * **Tamoxifen:** This selective estrogen receptor modulator (SERM) used in breast cancer is a well-known cause of vortex keratopathy and crystalline retinopathy. * **Indomethacin:** This NSAID is a classic cause of whorl-like corneal deposits, which are usually dose-dependent and reversible upon discontinuation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Vortex Keratopathy (CHAI-T):** **C**hloroquine/Hydroxychloroquine, **H**eamiodarone (Amiodarone - most common cause), **A**tovaquone, **I**ndomethacin, and **T**amoxifen. * **Fabry Disease:** The most important systemic (non-drug) cause of vortex keratopathy. If seen in a patient not on these medications, suspect an alpha-galactosidase A deficiency. * **Visual Impact:** Vortex keratopathy is usually asymptomatic and rarely affects visual acuity, thus drug discontinuation is seldom required unless systemic toxicity is suspected.

Question 46: Cornea verticillata is caused by which of the following medications?

A. Erythromycin
B. Amiodarone (Correct Answer)
C. Timolol
D. Tetracycline

Explanation: **Explanation:** **Cornea verticillata** (also known as vortex keratopathy) is characterized by fine, bilateral, golden-brown or greyish deposits in the corneal epithelium, typically arranged in a whorl-like pattern. **Why Amiodarone is correct:** Amiodarone is a Class III anti-arrhythmic drug known to cause lipidosis in the corneal epithelium. It binds to polar lipids, making them indigestible by lysosomal enzymes, leading to their accumulation. Nearly all patients on long-term amiodarone therapy develop these deposits. While they are usually asymptomatic and do not require discontinuation of the drug, they can occasionally cause visual halos or blurred vision. **Why other options are incorrect:** * **Erythromycin:** This is a macrolide antibiotic used topically for neonatal prophylaxis or bacterial conjunctivitis; it does not cause corneal deposits. * **Timolol:** A non-selective beta-blocker used to treat glaucoma. Its primary ocular side effects include stinging, dry eyes, and bradycardia, but not vortex keratopathy. * **Tetracycline:** While systemic tetracyclines can cause skin or tooth discoloration and are associated with pseudotumor cerebri, they do not cause the specific whorl-like corneal deposits seen in cornea verticillata. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cornea Verticillata (CHAI-T):** **C**hloroquine/Hydroxychloroquine, **H**eavy metals (Gold, Iron), **A**miodarone, **I**ndomethacin, and **T**amoxifen. * **Fabry Disease:** This is the most important systemic condition associated with cornea verticillata (due to glycosphingolipid accumulation). * **Reversibility:** Amiodarone-induced deposits are typically reversible upon cessation of the drug, though this is rarely necessary.

Question 47: Which is a recently used topical NSAID for ophthalmic use?

A. Indomethacin
B. Nepafenac (Correct Answer)
C. Flurbiprofen
D. Oxyphenbutazone

Explanation: **Explanation:** **Nepafenac** is the correct answer as it represents the newer generation of topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The key pharmacological concept behind Nepafenac is that it is a **prodrug**. Unlike conventional NSAIDs, Nepafenac is an amide derivative that exhibits superior intraocular penetration through the cornea. Once it reaches the iris, ciliary body, and retina, it is converted by intraocular hydrolases into **Amfenac**, a potent inhibitor of COX-1 and COX-2 enzymes. This makes it highly effective for managing pain and inflammation associated with cataract surgery and for preventing/treating **Cystoid Macular Edema (CME)**. **Analysis of Incorrect Options:** * **Indomethacin (A):** One of the oldest NSAIDs. While available in topical forms, it is less commonly used today due to a higher incidence of ocular surface irritation compared to newer agents. * **Flurbiprofen (C):** An older generation topical NSAID primarily used intraoperatively to maintain pupillary dilation (preventing miosis) during cataract surgery. * **Oxyphenbutazone (D):** An older pyrazolone derivative. It was traditionally used as an eye ointment for inflammatory conditions but has largely been phased out in modern ophthalmic practice due to the availability of more potent and safer alternatives. **High-Yield Clinical Pearls for NEET-PG:** * **Bromfenac** is another "recent" topical NSAID known for its long duration of action, allowing for **once-daily** dosing. * **Ketorolac (0.5%)** is frequently used for seasonal allergic conjunctivitis and post-operative inflammation. * **Side Effects:** Prolonged use of topical NSAIDs can lead to "corneal melting" (keratolysis), a serious complication that must be monitored. * **Indications:** Topical NSAIDs are the preferred choice over steroids when there is a risk of steroid-induced glaucoma or delayed wound healing.

Question 48: Thickening of eyelashes is a side effect of which medication?

A. Brimonidine
B. Propranolol
C. Latanoprost (Correct Answer)
D. Acetazolamide

Explanation: **Explanation:** **Latanoprost** is a Prostaglandin F2α (PGF2α) analogue used as a first-line treatment for Primary Open-Angle Glaucoma. It works by increasing the **uveoscleral outflow** of aqueous humor. A characteristic side effect of prostaglandin analogues (including Latanoprost, Bimatoprost, and Travoprost) is **Hypertrichosis**—the thickening, lengthening, and darkening of eyelashes. This occurs because prostaglandins prolong the **anagen (growth) phase** of the hair follicle. This side effect is so predictable that Bimatoprost is FDA-approved specifically for treating eyelash hypotrichosis. **Analysis of Incorrect Options:** * **Brimonidine:** An alpha-2 agonist. Its most common side effects are follicular conjunctivitis, lethargy, and dry mouth. It does not affect hair growth. * **Propranolol:** A non-selective beta-blocker. While topical beta-blockers (like Timolol) are used in glaucoma, they are more likely to cause systemic side effects (bradycardia, bronchospasm) rather than eyelash changes. * **Acetazolamide:** A Carbonic Anhydrase Inhibitor. Systemic use is associated with metabolic acidosis, hypokalemia, and paresthesia, but not hypertrichosis. **High-Yield Clinical Pearls for NEET-PG:** * **Other Side Effects of Latanoprost:** Irreversible darkening of the iris (increased melanin production), periocular skin pigmentation, and cystoid macular edema (CME) in aphakic patients. * **Mechanism of Action:** Prostaglandins are the only class that primarily increases **uveoscleral outflow** (others mostly decrease production or increase trabecular outflow). * **Contraindication:** Avoid in patients with active uveitis as they are pro-inflammatory.

Question 49: A 52-year-old female presented with a sudden attack of painful diminution of vision in the right eye, accompanied by colored halos and vomiting after watching a movie in a theater. On examination, the eye was stony hard. What is the first-line drug to be administered in this condition?

A. Mannitol
B. Latanoprost
C. Pilocarpine
D. Acetazolamide (Correct Answer)

Explanation: **Explanation:** The clinical presentation—sudden painful vision loss, colored halos, vomiting, and a "stony hard" eye following a dark environment (movie theater)—is a classic description of **Acute Angle-Closure Glaucoma (AACG)**. In the dark, pupillary dilation leads to iris-lens apposition, causing a pupillary block and a rapid rise in intraocular pressure (IOP). **Why Acetazolamide is the Correct Answer:** In an acute attack, the immediate goal is to lower IOP as rapidly as possible. **Systemic Acetazolamide (500mg IV or oral)** is the first-line treatment. It is a potent Carbonic Anhydrase Inhibitor that decreases the production of aqueous humor. It is preferred as the initial step because it acts rapidly and works even when the eye is too congested for topical drops to be effective. **Analysis of Incorrect Options:** * **Mannitol (A):** While Mannitol (an osmotic diuretic) is highly effective at lowering IOP, it is generally reserved as a second-line agent if Acetazolamide fails or if the IOP is extremely high. It requires intravenous access and careful monitoring of systemic fluid status. * **Latanoprost (B):** Prostaglandin analogues are the first-line for *Chronic* Open-Angle Glaucoma. They are not used in acute attacks as they take hours to work and can worsen inflammation. * **Pilocarpine (C):** Although it is the definitive medical treatment to open the angle (miotic), it **cannot** be used initially. When IOP is >40-50 mmHg, the iris sphincter becomes ischemic and unresponsive to pilocarpine. It is administered only after the IOP has been lowered by systemic agents. **Clinical Pearls for NEET-PG:** * **Definitive Treatment:** The definitive treatment for AACG is **Peripheral Iridotomy (YAG Laser)**, performed in both the affected and the fellow (prophylactic) eye. * **Drug of Choice for Chronic Open-Angle Glaucoma:** Latanoprost. * **Avoid in AACG:** Mydriatics (like Atropine) are strictly contraindicated as they worsen the angle closure.

Question 50: Acetazolamide decreases intraocular pressure by what mechanism?

A. Decreases aqueous humor production (Correct Answer)
B. Decreases vitreous volume
C. Increased drainage of aqueous
D. None of the above

Explanation: **Explanation:** **Mechanism of Action (Why A is correct):** Acetazolamide is a potent **Carbonic Anhydrase Inhibitor (CAI)**. In the eye, the enzyme carbonic anhydrase is present in the non-pigmented ciliary epithelium. It facilitates the reaction: $CO_2 + H_2O \rightleftharpoons H_2CO_3 \rightleftharpoons H^+ + HCO_3^-$. The secretion of aqueous humor is an active process dependent on the transport of sodium and bicarbonate ions. By inhibiting carbonic anhydrase, acetazolamide reduces the availability of bicarbonate ions, which in turn decreases the active transport of sodium into the posterior chamber. This osmotic shift leads to a **reduction in aqueous humor production by approximately 50-60%**, thereby lowering intraocular pressure (IOP). **Analysis of Incorrect Options:** * **B. Decreases vitreous volume:** This is the mechanism of **Hyperosmotic agents** (e.g., Mannitol, Glycerol). They create an osmotic gradient that draws water out of the vitreous into the bloodstream. * **C. Increased drainage of aqueous:** This is the mechanism of **Miotics** (pilocarpine - increases trabecular outflow) or **Prostaglandin analogues** (latanoprost - increases uveoscleral outflow). Acetazolamide has no effect on the outflow pathways. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** Systemic (Oral/IV). Topical CAIs include Dorzolamide and Brinzolamide. * **Indications:** Acute Angle Closure Glaucoma (emergency management) and prophylaxis before intraocular surgery. * **Side Effects:** Paresthesia (most common), metabolic acidosis, hypokalemia, and renal calculi. * **Contraindication:** It is a sulfonamide derivative; avoid in patients with **sulfa allergy** and those with severe hepatic or renal impairment.

Practice by Chapter

Ocular Pharmacokinetics

Practice Questions

Anti-infective Agents

Practice Questions

Anti-inflammatory Drugs

Practice Questions

Antiglaucoma Medications

Practice Questions

Mydriatics and Cycloplegics

Practice Questions

Ocular Lubricants

Practice Questions

Anti-VEGF Agents

Practice Questions

Ocular Diagnostic Agents

Practice Questions

Anesthetics in Ophthalmology

Practice Questions

Preservatives and Their Effects

Practice Questions

Ocular Toxicology

Practice Questions

Novel Drug Delivery Systems

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free